CI vs CLMT · P/E 2.4, rev $274.90B vs rev $4.19B
Cigna Corp (CI) versus Calumet Specialty Products Partners (CLMT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. CLMT currently screens at market cap $2.89B.
Not investment advice. Open the CI and CLMT stock pages for the full models.
Not investment advice.